Having trouble viewing this email? View it in your browser.
Musella Foundation Logo and Name of Email Blast
Monday, November 20, 2023
Issue 5945
Donations

Advocacy
Alert
NEW: July 2023
The time has come to rally for the Promising Pathway Act!

Click for details and to easily send letters.

Latest News

  • Copay Assistance Program is now open!        

      Thanks to generous donations, we are able to reopen our copay assistance program!  We have a lookback period of 3 months from when the completed application arrives so if you are approved, and have paid for a covered treatment in the last 3 months we can reimburse you!   This program can help pay for the following treatments:  Optune, Temodar, Avastin and Gleostine, as well as the generics / bioequivalents of these!  If you think you may need help, apply ASAP as the program might not be open too long. Remember, seeking help is never something to feel guilty about. We are here to alleviate some of the burdens in your life and provide support during challenging times. Don't hesitate to reach out and let us assist you.


  • GT Medical Technologies, Inc. Presents Use of GammaTile Therapy is Increasing in Time Across Several Brain Tumor Types at the 28th Annual Scientific Meeting and Education Day at the Society of Neuro-Oncology (SNO)        

     They reached a significant milestone - over 1,000 patients treated with GammaTile!  GammaTile is an FDA approved treatment for newly diagnosed and recurrent primary or metastatic brain tumors.  It is implanted at the time of surgery and releases radiation to the tumor bed.  



Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details

To view past stories go to : https://virtualtrials.org/newsblast.cfm
To submit a story/press release go to: click here To unsubscribe, click here.
The article commentaries are the opinions of Al Musella, DPM and do not represent the official position of the Musella Foundation. Copyright 1992-2023 Musella Foundation - All rights reserved. No part of the Brain Tumor News Blast can be reproduced without the express written permission of the Musella Foundation.